|
MBNL2 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 2.40129999995453E-07 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
3.24650000216309E-08 |
| Normal-vs-Stage2 |
7.153500E-02 |
| Normal-vs-Stage3 |
9.016100E-03 |
| Normal-vs-Stage4 |
8.850800E-01 |
| Stage1-vs-Stage2 |
1.759830E-01 |
| Stage1-vs-Stage3 |
5.049400E-01 |
| Stage1-vs-Stage4 |
1.826440E-02 |
| Stage2-vs-Stage3 |
5.990400E-01 |
| Stage2-vs-Stage4 |
3.464800E-01 |
| Stage3-vs-Stage4 |
1.766040E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.95239999944974E-07 |
| Normal-vs-AfricanAmerican |
4.371100E-04 |
| Normal-vs-Asian |
1.982220E-03 |
| Caucasian-vs-AfricanAmerican |
8.157600E-01 |
| Caucasian-vs-Asian |
6.037400E-01 |
| AfricanAmerican-vs-Asian |
6.220400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.68300000047417E-07 |
| Normal-vs-Female |
2.179300E-04 |
| Male-vs-Female |
4.827000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
6.72660000033964E-07 |
| Normal-vs-Extreme_Weight |
5.61049999792118E-08 |
| Normal-vs-Obese |
2.198900E-03 |
| Normal-vs-Extreme_Obese |
2.008300E-02 |
| Normal_Weight-vs-Extreme_Weight |
8.776800E-01 |
| Normal_Weight-vs-Obese |
8.463600E-02 |
| Normal_Weight-vs-Extreme_Obese |
9.774600E-01 |
| Extreme_Weight-vs-Obese |
6.191900E-02 |
| Extreme_Weight-vs-Extreme_Obese |
9.101400E-01 |
| Obese-vs-Extreme_Obese |
3.303600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.820980E-04 |
| Normal-vs-Age(41-60Yrs) |
1.000330E-03 |
| Normal-vs-Age(61-80Yrs) |
7.86370002447967E-09 |
| Normal-vs-Age(81-100Yrs) |
4.84130000000249E-06 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
2.267400E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
8.431800E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
3.645400E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
3.582400E-03 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
4.926200E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
4.737000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
1.15860000038381E-07 |
| Normal-VS-Type2 PRCC |
5.37979999992722E-07 |
| Normal-VS-KIRP CIMP |
8.027700E-04 |
| Normal-VS-Unclassified PRCC |
7.036200E-01 |
| Type1 PRCC-VS-Type2 PRCC |
3.388200E-01 |
| Type1 PRCC-VS-KIRP CIMP |
7.013800E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
1.812460E-02 |
| Type2 PRCC-VS-KIRP CIMP |
9.216000E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
7.802100E-03 |
| KIRP CIMP-VS-Unclassified PRCC |
1.294050E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
7.00890000038257E-07 |
| Normal-vs-N1 |
3.223800E-01 |
| Normal-vs-N2 |
1.483960E-03 |
| N0-vs-N1 |
9.857900E-02 |
| N0-vs-N2 |
6.458600E-01 |
| N1-vs-N2 |
4.231700E-02 |
|
|
